Epstein-Barr virus-positive mucocutaneous ulcer in a patient with ulcerative colitis: a recently described entity to take into account
We present the case of a 31-year-old man with ulcerative proctitis being treated with azathioprine (AZA) and adalimumab (ADA), who was admitted to the hospital due to suspicion of a moderate-severe flare of ulcerative proctitis. Microbiological stool analyses were negative, with a positive fecal calprotectin test (2700 mg/kg). Rectoscopy showed severe endoscopic activity, taking multiple biopsies. Intravenous steroids were started at a dose of 60 mg/day. He presented a favorable clinical and analytical evolution, being discharged from the hospital. The histological results were received at gastroenterology consultation, being compatible with EBVMCU. AZA and ADA were withdrawn, whereas descending steroid regimen and oral and topical mesalazine were continued, being the clinical response adequate.PMID:38258758 | DOI:10.17235/reed.2024.10168/2023
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Authors: Álvaro Yagüe Parada Orencio Bosch Esteva Daniel Calero Bar ón Andrea Blanco Fern ández V íctor Manuel Castellano Megías Sara Aurora Rodr íguez Vargas Source Type: research
More News: Gastroenterology | Hospitals | Humira | Inflammatory Bowel Disease | Microbiology | Skin | Skin Biopsy | Ulcerative Colitis